野村研究报告指出，估计京东健康(06618.HK)第三季度总营收维持强劲增长动能，料按年增24%，受药品、营养、医疗器械销售料分别增长30%、20%及10%驱动；认为公司药品营收的显著增长，受益于处方药从从医院流向院外趋势，以及药品销售线上渗透加速。野村表示，凭借公司优越的供应链能力，京东健康很可能在这一趋势中超越同行增长并扩大市场份额。值得注意的是，野村观察到京东健康第三季度营养品销售稳健成长，...
Source Link野村研究报告指出，估计京东健康(06618.HK)第三季度总营收维持强劲增长动能，料按年增24%，受药品、营养、医疗器械销售料分别增长30%、20%及10%驱动；认为公司药品营收的显著增长，受益于处方药从从医院流向院外趋势，以及药品销售线上渗透加速。野村表示，凭借公司优越的供应链能力，京东健康很可能在这一趋势中超越同行增长并扩大市场份额。值得注意的是，野村观察到京东健康第三季度营养品销售稳健成长，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.